Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

3.7%

1 terminated/withdrawn out of 27 trials

Success Rate

95.5%

+8.9% vs industry average

Late-Stage Pipeline

41%

11 trials in Phase 3/4

Results Transparency

10%

2 of 21 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

10(52.6%)

N/A

5(26.3%)

Phase 2

2(10.5%)

Early Phase 1

1(5.3%)

Phase 3

1(5.3%)

19Total

Phase 4(10)

N/A(5)

Phase 2(2)

Early Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT07311499Not ApplicableNot Yet Recruiting

Improvement of Sleep in COPD Patients Through Inhalation Management Education by Nurse.

Role: lead

NCT01475123Phase 4Active Not Recruiting

Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

Role: lead

NCT05525156Phase 2Suspended

The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy

Role: collaborator

NCT01042730Not ApplicableCompleted

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Role: collaborator

NCT02565264Early Phase 1Unknown

Effect of Plasma Derived Exosomes on Cutaneous Wound Healing

Role: lead

NCT03248232Completed

Assessments of Thrombus Formation in TAVI

Role: lead

NCT02528006Phase 2Completed

Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges

Role: lead

NCT00737945Completed

Prognostic Value of Endothelial Dysfunction and Coronary Complexity

Role: lead

NCT02033837Completed

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

Role: lead

NCT00110448Phase 4Completed

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

Role: lead

NCT01075698Phase 4Completed

A Trial of Telmisartan Prevention of Cardiovascular Disease

Role: lead

NCT01032109Not ApplicableCompleted

Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Role: lead

NCT00140790Phase 4Terminated

Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study

Role: lead

NCT00828347Not ApplicableCompleted

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

Role: lead

NCT01043380Phase 4Completed

Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound

Role: lead

NCT00265239Phase 4Completed

Pilot Study of Edaravone to Treat Acute Myocardial Infarction

Role: lead

NCT00876512Completed

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study

Role: lead

NCT02131935Completed

Impaired Peripheral Endothelial Function and In-stent Restenosis

Role: lead